ArticleMaterials today. Bio2026
Hyaluronan open-pit nanofibrils with spontaneous cell-matrix assembly for advanced osteochondral defect repair.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While hyaluronic acid (HA) inherently promotes chondrogenesis, its hydrophilic character and lack of receptor-specific ligands impede robust cell adhesion - underscoring the need for nanofibrous matrices that emulate the extracellular microenvironment to enhance cell - matrix interactions. Therefore, we designed HA-based nanofibrils (NFs) with a high capability of self-assembly with adipose - derived stem cells (ADSCs) to enhance cell - matrix interaction, thereby promoting chondrogenesis. To address the electrospinning challenges arising from the high viscosity and hydrophilicity of hyaluronic acid (HA), a co-axial electrospinning technique was employed to fabricate core - sheath nanofibers consisting of a polycaprolactone (PCL)/poly(ethylene glycol) (PEG) sheath and an HA core (PCL/PEG@HA nanofibers). After chemical crosslinking of the HA core and the following etching of PEG on the sheath, the engineered nanofibers exhibited considerable HA displays on the surfaces (PCL@HA nanofibers). The fragmented nanofibers (PCL@HA NFs) could be self-assembled into cells - NFs matrix with ADSCs. Owing to HA exposure on the NFs, ADSCs exhibited higher cell proliferation and enhanced chondrogenic differentiation when the spontaneously assembled matrix of ADSCs - PCL@HA NFs was incubated in a reduced chondrogenic medium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.